DE69815854D1 - Polyhydroxybutylpyrazinen, deren herstellung und diese enthaltende arzneimitteln - Google Patents

Polyhydroxybutylpyrazinen, deren herstellung und diese enthaltende arzneimitteln

Info

Publication number
DE69815854D1
DE69815854D1 DE69815854T DE69815854T DE69815854D1 DE 69815854 D1 DE69815854 D1 DE 69815854D1 DE 69815854 T DE69815854 T DE 69815854T DE 69815854 T DE69815854 T DE 69815854T DE 69815854 D1 DE69815854 D1 DE 69815854D1
Authority
DE
Germany
Prior art keywords
polyhydroxybutylpyrazines
production
products containing
medicinal products
formulaincluding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69815854T
Other languages
English (en)
Other versions
DE69815854T2 (de
Inventor
Georges Bashiardes
Jean-Christophe Carry
Michel Evers
Bruno Filoche
Serge Mignani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE69815854D1 publication Critical patent/DE69815854D1/de
Application granted granted Critical
Publication of DE69815854T2 publication Critical patent/DE69815854T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
DE69815854T 1997-07-17 1998-07-15 Polyhydroxybutylpyrazinen, deren herstellung und diese enthaltende arzneimitteln Expired - Lifetime DE69815854T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9709059 1997-07-17
FR9709059A FR2766183B1 (fr) 1997-07-17 1997-07-17 Medicaments contenant des polyhydroxybutylpyrazines, les polyhydroxybutylpyrazines nouvelles et leur preparation
PCT/FR1998/001543 WO1999003841A1 (fr) 1997-07-17 1998-07-15 Polyhydroxybutylpyrazines, leur preparation et medicaments les contenant

Publications (2)

Publication Number Publication Date
DE69815854D1 true DE69815854D1 (de) 2003-07-31
DE69815854T2 DE69815854T2 (de) 2004-05-13

Family

ID=9509301

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69815854T Expired - Lifetime DE69815854T2 (de) 1997-07-17 1998-07-15 Polyhydroxybutylpyrazinen, deren herstellung und diese enthaltende arzneimitteln

Country Status (25)

Country Link
US (1) US6288066B1 (de)
EP (1) EP1001942B1 (de)
JP (1) JP4443033B2 (de)
KR (1) KR20010021871A (de)
CN (1) CN1264368A (de)
AT (1) ATE243683T1 (de)
AU (1) AU745905B2 (de)
BR (1) BR9810595A (de)
CA (1) CA2296725C (de)
CZ (1) CZ290896B6 (de)
DE (1) DE69815854T2 (de)
DK (1) DK1001942T3 (de)
ES (1) ES2196595T3 (de)
FR (1) FR2766183B1 (de)
HU (1) HUP0004661A3 (de)
IL (1) IL134039A0 (de)
MX (1) MXPA00000437A (de)
NO (1) NO20000199L (de)
NZ (1) NZ502279A (de)
PL (1) PL338147A1 (de)
PT (1) PT1001942E (de)
RU (1) RU2186773C2 (de)
SK (1) SK462000A3 (de)
WO (1) WO1999003841A1 (de)
ZA (1) ZA986336B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802816A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique inhibiteur d'alpha-glucosidase
FR2802815A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique agoniste du recepteur gamma-active par le proliferateur de peroxisome
FR2802813A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique de la famille des biguandes
US6794506B2 (en) * 2000-07-21 2004-09-21 Elan Pharmaceuticals, Inc. 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
DE102005047647A1 (de) * 2005-10-05 2007-04-12 Merck Patent Gmbh a,a'-Dihydroxyketonderivate und deren Verwendung als UV-Filter
US8278459B2 (en) 2007-03-19 2012-10-02 Dsm Ip Assets B.V. UV-filter compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744365B1 (fr) * 1996-02-06 1998-02-27 Inst Malgache Rech Appl Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments

Also Published As

Publication number Publication date
JP2001510185A (ja) 2001-07-31
JP4443033B2 (ja) 2010-03-31
KR20010021871A (ko) 2001-03-15
EP1001942A1 (de) 2000-05-24
ATE243683T1 (de) 2003-07-15
EP1001942B1 (de) 2003-06-25
BR9810595A (pt) 2000-09-12
NO20000199D0 (no) 2000-01-14
AU8810398A (en) 1999-02-10
MXPA00000437A (es) 2002-04-17
AU745905B2 (en) 2002-04-11
RU2186773C2 (ru) 2002-08-10
CA2296725A1 (fr) 1999-01-28
ZA986336B (en) 1999-01-27
PT1001942E (pt) 2003-11-28
IL134039A0 (en) 2001-04-30
US6288066B1 (en) 2001-09-11
HUP0004661A2 (hu) 2001-11-28
FR2766183B1 (fr) 1999-08-27
CN1264368A (zh) 2000-08-23
FR2766183A1 (fr) 1999-01-22
SK462000A3 (en) 2000-06-12
CZ290896B6 (cs) 2002-11-13
CA2296725C (fr) 2008-11-18
HUP0004661A3 (en) 2001-12-28
DE69815854T2 (de) 2004-05-13
PL338147A1 (en) 2000-09-25
NO20000199L (no) 2000-01-14
CZ2000121A3 (cs) 2000-05-17
NZ502279A (en) 2002-04-26
ES2196595T3 (es) 2003-12-16
DK1001942T3 (da) 2003-10-20
WO1999003841A1 (fr) 1999-01-28

Similar Documents

Publication Publication Date Title
ATE494009T1 (de) Prodrugs, ihre herstellung und verwendung als arzneimittel
DE69604653T2 (de) Taxol derivate, deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen
FI942074A0 (fi) nor-sappijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina
DE3669315D1 (de) Phenoxyalkylaminopyrimidinderivate, deren herstellung und diese enthaltende insektizide und akarizide zusammensetzungen.
NO174877C (no) Fremgangsmåte for fremstilling av et legemiddel med antitumorvirkning
DE69715888T2 (de) Pyridylalken- und pyridylalkin-säureamide als cytostatika und immunosuppressive arzneimittel
ATE194920T1 (de) Pro-prodrugs, ihre herstellung und anwendung
ATE231849T1 (de) Cyclopentabenzofuran-derivate und ihre verwendung
ATE243683T1 (de) Polyhydroxybutylpyrazinen, deren herstellung und diese enthaltende arzneimitteln
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
DE69808922D1 (de) Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen
NO932502D0 (no) Nye fosfolipidderivater
DE69706441D1 (de) Tetracyclische aromatische retinoide verbindungen, ihre herstellung und verwendung
DE3880348T2 (de) N-substituierte alpha-mercaptomethylbenzenpropanamid-derivate, ihre herstellung, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen.
ATE219498T1 (de) 14,15-alpha-methylen-equileninderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC